Development of a novel prognostic signature for predicting the overall survival of bladder cancer patients

Background: Bladder cancer is one of the most common malignancies. So far, no effective biomarker for bladder cancer prognosis has been identified. Aberrant DNA methylation is frequently observed in the bladder cancer and holds considerable promise as a biomarker for predicting the overall survival...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biosci Rep
Asıl Yazarlar: Tang, Huamei, Kan, Lijuan, Ou, Tong, Chen, Dayang, Dou, Xiaowen, Wu, Wei, Ji, Xiang, Wang, Mengmeng, Zong, Zengyan, Mo, Hongmei, Zhang, Xiuming, Xiong, Dan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Portland Press Ltd. 2020
Konular:
Bioinformatics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7286875/
https://ncbi.nlm.nih.gov/pubmed/32441304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20194432
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller